Type to search

Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis | Pharmtech Focus
seqWell’s plexWell Technology Selected by California Conservation Genomics Project for Conservation Genomics Research | Pharmtech Focus
New Novartis Data Demonstrate Only Kisqali® Offers More Life in the First-line Setting for Postmenopausal HR+/HER2- Advanced Breast Cancer Patients | Pharmtech Focus